Skip to main content

Table 3 Prevalence of established cardiovascular disease according to the presence of cardiac and/or renal damage.

From: Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study

 

No ECG-LVH and no renal damage

(28.6%)

(Group A)

ECG-LVH only

(5.4%)

(Group B)

Renal damage only

(48.4%)

(Group C)

ECG-LVH and renal damage

(17.6%)

(Group D)

Cardiovascular disease (any), %

37.7%

58.9%A

51.4%A

70.6%A, C

Angina, %

12.4%

19.7%A

14.7%

22.0%A, C

Myocardial infarction, %

13.1%

25.4%

17.5%

28.2%A, C

Heart failure, %

10.3%

23.8%A

20.6%A

33.8%A

Peripheral vascular disease, %

6.1%

10.8%

14.9%A

28.0%A, B, C

Stroke, %

11.9%

13.8%

18.2%A

23.7%A

Atrial fibrillation, %

7.8%

18.0%A

15.3%A

22.5%A, C

  1. ECG-LVH: electrocardiographic left ventricular hypertrophy. Superscripts (A, B, C, D) mean p < 0.05 compared to the indicated group.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840